Step 1
The prescription path
For the peptides that are FDA-approved medicines — the GLP-1s like tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy), or tesamorelin(Egrifta) — there's an official route: you see a doctor, they prescribe it, and a pharmacy fills it. This is the most “legitimate” and best-regulated path, and it's also where you're most likely to hit a cost wall.
How it works
You get a prescription from a licensed prescriber — a primary care doctor, an endocrinologist, a weight-management clinic, or an online telehealth provider. The prescription goes to a pharmacy (retail, mail-order, or compounding). That's it — the "official" version of the four routes.
The cost picture
| Factor | What you should know |
|---|---|
| List price (no insurance) | Brand-name GLP-1s often carry a very high monthly list price — commonly in the $800–$1,200/month range before any discount. This is the headline number, not what most people actually pay. |
| With insurance | Coverage varies enormously. Some plans cover GLP-1s for diabetes readily but are restrictive for weight loss. Copays + coinsurance can range from a modest co-pay to a few hundred dollars a month depending on your plan. |
| The catch | Insurance may require prior authorization, step therapy, or a qualifying diagnosis — and some plans simply don't cover weight-loss use. This is the biggest reason people explore other routes. |
Important: exact prices and coverage change constantly and vary by plan, region, and pharmacy. Treat the numbers above as a general sense of the range — always check your own insurance and pharmacy for the real figure.
Why this route matters to you: if a peptide is FDA-approved, the prescription path is the one with the clearest regulation, real quality control, and legitimate medical oversight. For those compounds, this is the reference point every other route is compared against.
Educational content — not medical advice.